Klebsiella oxytoca causes colonization resistance against multidrug-resistant K. pneumoniae in the gut via cooperative carbohydrate competition

Gut colonization with multidrug-resistant (MDR) bacteria enhances the risk of bloodstream infections in susceptible individuals. We demonstrate highly variable degrees of ex vivo colonization resistance against a carbapenem-resistant Klebsiella pneumoniae strain in human feces samples and subsequent...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cell host & microbe 2021-11, Vol.29 (11), p.1663-1679.e7
Hauptverfasser: Osbelt, Lisa, Wende, Marie, Almási, Éva, Derksen, Elisabeth, Muthukumarasamy, Uthayakumar, Lesker, Till R., Galvez, Eric J.C., Pils, Marina C., Schalk, Enrico, Chhatwal, Patrick, Färber, Jacqueline, Neumann-Schaal, Meina, Fischer, Thomas, Schlüter, Dirk, Strowig, Till
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1679.e7
container_issue 11
container_start_page 1663
container_title Cell host & microbe
container_volume 29
creator Osbelt, Lisa
Wende, Marie
Almási, Éva
Derksen, Elisabeth
Muthukumarasamy, Uthayakumar
Lesker, Till R.
Galvez, Eric J.C.
Pils, Marina C.
Schalk, Enrico
Chhatwal, Patrick
Färber, Jacqueline
Neumann-Schaal, Meina
Fischer, Thomas
Schlüter, Dirk
Strowig, Till
description Gut colonization with multidrug-resistant (MDR) bacteria enhances the risk of bloodstream infections in susceptible individuals. We demonstrate highly variable degrees of ex vivo colonization resistance against a carbapenem-resistant Klebsiella pneumoniae strain in human feces samples and subsequently isolate diverse K. oxytoca strains from protected donors. Several of these K. oxytoca strains reduce gut colonization of MDR K. pneumoniae strains in antibiotic-treated and gnotobiotic mouse models. Comparative analysis of K. oxytoca strains coupled with CRISPR-Cas9-mediated deletion of casA, a protein essential for utilization of selected beta-glucosides, identified competition for specific carbohydrates as key in promoting colonization resistance. In addition to direct competition between K. oxytoca and K. pneumoniae, cooperation with additional commensals is required to reestablish full colonization resistance and gut decolonization. Finally, humanized microbiota mice generated from K. pneumoniae-susceptible donors are protected by K. oxytoca administration, demonstrating the potential of commensal K. oxytoca strains as next-generation probiotics. [Display omitted] •Ex vivo colonization resistance against K. pneumoniae is variable between individuals•Diverse commensal Klebsiella oxytoca strains are isolated from protected individuals•K. oxytoca establishes colonization resistance against of K. pneumoniae in vivo•Cooperation with commensal bacteria restricts nutrient availability in the gut Gut colonization with multidrug-resistant enterobacteria increases risk of bloodstream infections. Osbelt et al. characterize the ability of human stools to inhibit growth of multidrug-resistant Klebsiella pneumoniae. Commensal Klebsiella oxytoca strains were identified in protected human donors, which in cooperation with other commensals outcompete K. pneumoniae through beta-glucoside utilization in mice.
doi_str_mv 10.1016/j.chom.2021.09.003
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2579628551</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1931312821004194</els_id><sourcerecordid>2579628551</sourcerecordid><originalsourceid>FETCH-LOGICAL-c400t-9ddfcf7f842b0682934c8ae9520a17a7a0a2086e240f3c5d2db8d6ce147397923</originalsourceid><addsrcrecordid>eNp9Ubtu3DAQJAIHsWPnB1IELN1IWVJPAm4Mw3nABtIkNUGRqzseJFEhqYPPX5FPyLfky0L57JSpdhc7M4udIeQ9g5wBqz_ucr11Y86BsxxEDlC8ImdMFGVWQy1OnnqWFYy3p-RtCDuAqoKGvSGnRVkz4KI4I7_uBuyCxWFQ1D0cotOKarUEDFS7wU32UUXrJuox2BDVpJGqjbJTiHRchmiNXzbZyzLSu_zP73nCZUxMhdRONG6RbpZI9zYJOzejT4J7TEd857YHk8Y0uHHGaNdLF-R1r4aA757rOfnx6fb7zZfs_tvnrzfX95kuAWImjOl13_RtyTuo2_RLqVuFouKgWKMaBYpDWyMvoS90ZbjpWlNrZGVTiEbw4pxcHnVn734uGKIcbdCrDxO6JUheNaLmbVWxBOVHqPYuBI-9nL0dlT9IBnJNQu7kmoRck5AgZEoikT486y_diOYf5cX6BLg6AjB9ubfoZdAWk8HGetRRGmf_p_8XHNGfBA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2579628551</pqid></control><display><type>article</type><title>Klebsiella oxytoca causes colonization resistance against multidrug-resistant K. pneumoniae in the gut via cooperative carbohydrate competition</title><source>MEDLINE</source><source>Cell Press Free Archives</source><source>Elsevier ScienceDirect Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Osbelt, Lisa ; Wende, Marie ; Almási, Éva ; Derksen, Elisabeth ; Muthukumarasamy, Uthayakumar ; Lesker, Till R. ; Galvez, Eric J.C. ; Pils, Marina C. ; Schalk, Enrico ; Chhatwal, Patrick ; Färber, Jacqueline ; Neumann-Schaal, Meina ; Fischer, Thomas ; Schlüter, Dirk ; Strowig, Till</creator><creatorcontrib>Osbelt, Lisa ; Wende, Marie ; Almási, Éva ; Derksen, Elisabeth ; Muthukumarasamy, Uthayakumar ; Lesker, Till R. ; Galvez, Eric J.C. ; Pils, Marina C. ; Schalk, Enrico ; Chhatwal, Patrick ; Färber, Jacqueline ; Neumann-Schaal, Meina ; Fischer, Thomas ; Schlüter, Dirk ; Strowig, Till</creatorcontrib><description>Gut colonization with multidrug-resistant (MDR) bacteria enhances the risk of bloodstream infections in susceptible individuals. We demonstrate highly variable degrees of ex vivo colonization resistance against a carbapenem-resistant Klebsiella pneumoniae strain in human feces samples and subsequently isolate diverse K. oxytoca strains from protected donors. Several of these K. oxytoca strains reduce gut colonization of MDR K. pneumoniae strains in antibiotic-treated and gnotobiotic mouse models. Comparative analysis of K. oxytoca strains coupled with CRISPR-Cas9-mediated deletion of casA, a protein essential for utilization of selected beta-glucosides, identified competition for specific carbohydrates as key in promoting colonization resistance. In addition to direct competition between K. oxytoca and K. pneumoniae, cooperation with additional commensals is required to reestablish full colonization resistance and gut decolonization. Finally, humanized microbiota mice generated from K. pneumoniae-susceptible donors are protected by K. oxytoca administration, demonstrating the potential of commensal K. oxytoca strains as next-generation probiotics. [Display omitted] •Ex vivo colonization resistance against K. pneumoniae is variable between individuals•Diverse commensal Klebsiella oxytoca strains are isolated from protected individuals•K. oxytoca establishes colonization resistance against of K. pneumoniae in vivo•Cooperation with commensal bacteria restricts nutrient availability in the gut Gut colonization with multidrug-resistant enterobacteria increases risk of bloodstream infections. Osbelt et al. characterize the ability of human stools to inhibit growth of multidrug-resistant Klebsiella pneumoniae. Commensal Klebsiella oxytoca strains were identified in protected human donors, which in cooperation with other commensals outcompete K. pneumoniae through beta-glucoside utilization in mice.</description><identifier>ISSN: 1931-3128</identifier><identifier>EISSN: 1934-6069</identifier><identifier>DOI: 10.1016/j.chom.2021.09.003</identifier><identifier>PMID: 34610293</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>16S rRNA gene sequencing ; Adaptive Immunity ; Adult ; Animals ; Bacterial Proteins - genetics ; Bacterial Proteins - metabolism ; beta-glucosides ; Carbohydrate Metabolism ; Child ; colonization resistance ; Drug Resistance, Multiple, Bacterial ; enteric infections ; Feces - microbiology ; Gastrointestinal Microbiome ; Gastrointestinal Tract - microbiology ; Germ-Free Life ; Glucosides - metabolism ; humanized mouse models ; Humans ; intestinal microbiota ; Klebsiella Infections - immunology ; Klebsiella Infections - microbiology ; Klebsiella oxytoca ; Klebsiella oxytoca - genetics ; Klebsiella oxytoca - isolation &amp; purification ; Klebsiella oxytoca - physiology ; Klebsiella pneumoniae ; Klebsiella pneumoniae - drug effects ; Klebsiella pneumoniae - growth &amp; development ; Mice ; Mice, Inbred C57BL ; Microbial Interactions ; multidrug-resistant bacteria ; probiotics</subject><ispartof>Cell host &amp; microbe, 2021-11, Vol.29 (11), p.1663-1679.e7</ispartof><rights>2021 Elsevier Inc.</rights><rights>Copyright © 2021 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c400t-9ddfcf7f842b0682934c8ae9520a17a7a0a2086e240f3c5d2db8d6ce147397923</citedby><cites>FETCH-LOGICAL-c400t-9ddfcf7f842b0682934c8ae9520a17a7a0a2086e240f3c5d2db8d6ce147397923</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1931312821004194$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27903,27904,65309</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34610293$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Osbelt, Lisa</creatorcontrib><creatorcontrib>Wende, Marie</creatorcontrib><creatorcontrib>Almási, Éva</creatorcontrib><creatorcontrib>Derksen, Elisabeth</creatorcontrib><creatorcontrib>Muthukumarasamy, Uthayakumar</creatorcontrib><creatorcontrib>Lesker, Till R.</creatorcontrib><creatorcontrib>Galvez, Eric J.C.</creatorcontrib><creatorcontrib>Pils, Marina C.</creatorcontrib><creatorcontrib>Schalk, Enrico</creatorcontrib><creatorcontrib>Chhatwal, Patrick</creatorcontrib><creatorcontrib>Färber, Jacqueline</creatorcontrib><creatorcontrib>Neumann-Schaal, Meina</creatorcontrib><creatorcontrib>Fischer, Thomas</creatorcontrib><creatorcontrib>Schlüter, Dirk</creatorcontrib><creatorcontrib>Strowig, Till</creatorcontrib><title>Klebsiella oxytoca causes colonization resistance against multidrug-resistant K. pneumoniae in the gut via cooperative carbohydrate competition</title><title>Cell host &amp; microbe</title><addtitle>Cell Host Microbe</addtitle><description>Gut colonization with multidrug-resistant (MDR) bacteria enhances the risk of bloodstream infections in susceptible individuals. We demonstrate highly variable degrees of ex vivo colonization resistance against a carbapenem-resistant Klebsiella pneumoniae strain in human feces samples and subsequently isolate diverse K. oxytoca strains from protected donors. Several of these K. oxytoca strains reduce gut colonization of MDR K. pneumoniae strains in antibiotic-treated and gnotobiotic mouse models. Comparative analysis of K. oxytoca strains coupled with CRISPR-Cas9-mediated deletion of casA, a protein essential for utilization of selected beta-glucosides, identified competition for specific carbohydrates as key in promoting colonization resistance. In addition to direct competition between K. oxytoca and K. pneumoniae, cooperation with additional commensals is required to reestablish full colonization resistance and gut decolonization. Finally, humanized microbiota mice generated from K. pneumoniae-susceptible donors are protected by K. oxytoca administration, demonstrating the potential of commensal K. oxytoca strains as next-generation probiotics. [Display omitted] •Ex vivo colonization resistance against K. pneumoniae is variable between individuals•Diverse commensal Klebsiella oxytoca strains are isolated from protected individuals•K. oxytoca establishes colonization resistance against of K. pneumoniae in vivo•Cooperation with commensal bacteria restricts nutrient availability in the gut Gut colonization with multidrug-resistant enterobacteria increases risk of bloodstream infections. Osbelt et al. characterize the ability of human stools to inhibit growth of multidrug-resistant Klebsiella pneumoniae. Commensal Klebsiella oxytoca strains were identified in protected human donors, which in cooperation with other commensals outcompete K. pneumoniae through beta-glucoside utilization in mice.</description><subject>16S rRNA gene sequencing</subject><subject>Adaptive Immunity</subject><subject>Adult</subject><subject>Animals</subject><subject>Bacterial Proteins - genetics</subject><subject>Bacterial Proteins - metabolism</subject><subject>beta-glucosides</subject><subject>Carbohydrate Metabolism</subject><subject>Child</subject><subject>colonization resistance</subject><subject>Drug Resistance, Multiple, Bacterial</subject><subject>enteric infections</subject><subject>Feces - microbiology</subject><subject>Gastrointestinal Microbiome</subject><subject>Gastrointestinal Tract - microbiology</subject><subject>Germ-Free Life</subject><subject>Glucosides - metabolism</subject><subject>humanized mouse models</subject><subject>Humans</subject><subject>intestinal microbiota</subject><subject>Klebsiella Infections - immunology</subject><subject>Klebsiella Infections - microbiology</subject><subject>Klebsiella oxytoca</subject><subject>Klebsiella oxytoca - genetics</subject><subject>Klebsiella oxytoca - isolation &amp; purification</subject><subject>Klebsiella oxytoca - physiology</subject><subject>Klebsiella pneumoniae</subject><subject>Klebsiella pneumoniae - drug effects</subject><subject>Klebsiella pneumoniae - growth &amp; development</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Microbial Interactions</subject><subject>multidrug-resistant bacteria</subject><subject>probiotics</subject><issn>1931-3128</issn><issn>1934-6069</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9Ubtu3DAQJAIHsWPnB1IELN1IWVJPAm4Mw3nABtIkNUGRqzseJFEhqYPPX5FPyLfky0L57JSpdhc7M4udIeQ9g5wBqz_ucr11Y86BsxxEDlC8ImdMFGVWQy1OnnqWFYy3p-RtCDuAqoKGvSGnRVkz4KI4I7_uBuyCxWFQ1D0cotOKarUEDFS7wU32UUXrJuox2BDVpJGqjbJTiHRchmiNXzbZyzLSu_zP73nCZUxMhdRONG6RbpZI9zYJOzejT4J7TEd857YHk8Y0uHHGaNdLF-R1r4aA757rOfnx6fb7zZfs_tvnrzfX95kuAWImjOl13_RtyTuo2_RLqVuFouKgWKMaBYpDWyMvoS90ZbjpWlNrZGVTiEbw4pxcHnVn734uGKIcbdCrDxO6JUheNaLmbVWxBOVHqPYuBI-9nL0dlT9IBnJNQu7kmoRck5AgZEoikT486y_diOYf5cX6BLg6AjB9ubfoZdAWk8HGetRRGmf_p_8XHNGfBA</recordid><startdate>20211110</startdate><enddate>20211110</enddate><creator>Osbelt, Lisa</creator><creator>Wende, Marie</creator><creator>Almási, Éva</creator><creator>Derksen, Elisabeth</creator><creator>Muthukumarasamy, Uthayakumar</creator><creator>Lesker, Till R.</creator><creator>Galvez, Eric J.C.</creator><creator>Pils, Marina C.</creator><creator>Schalk, Enrico</creator><creator>Chhatwal, Patrick</creator><creator>Färber, Jacqueline</creator><creator>Neumann-Schaal, Meina</creator><creator>Fischer, Thomas</creator><creator>Schlüter, Dirk</creator><creator>Strowig, Till</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20211110</creationdate><title>Klebsiella oxytoca causes colonization resistance against multidrug-resistant K. pneumoniae in the gut via cooperative carbohydrate competition</title><author>Osbelt, Lisa ; Wende, Marie ; Almási, Éva ; Derksen, Elisabeth ; Muthukumarasamy, Uthayakumar ; Lesker, Till R. ; Galvez, Eric J.C. ; Pils, Marina C. ; Schalk, Enrico ; Chhatwal, Patrick ; Färber, Jacqueline ; Neumann-Schaal, Meina ; Fischer, Thomas ; Schlüter, Dirk ; Strowig, Till</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c400t-9ddfcf7f842b0682934c8ae9520a17a7a0a2086e240f3c5d2db8d6ce147397923</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>16S rRNA gene sequencing</topic><topic>Adaptive Immunity</topic><topic>Adult</topic><topic>Animals</topic><topic>Bacterial Proteins - genetics</topic><topic>Bacterial Proteins - metabolism</topic><topic>beta-glucosides</topic><topic>Carbohydrate Metabolism</topic><topic>Child</topic><topic>colonization resistance</topic><topic>Drug Resistance, Multiple, Bacterial</topic><topic>enteric infections</topic><topic>Feces - microbiology</topic><topic>Gastrointestinal Microbiome</topic><topic>Gastrointestinal Tract - microbiology</topic><topic>Germ-Free Life</topic><topic>Glucosides - metabolism</topic><topic>humanized mouse models</topic><topic>Humans</topic><topic>intestinal microbiota</topic><topic>Klebsiella Infections - immunology</topic><topic>Klebsiella Infections - microbiology</topic><topic>Klebsiella oxytoca</topic><topic>Klebsiella oxytoca - genetics</topic><topic>Klebsiella oxytoca - isolation &amp; purification</topic><topic>Klebsiella oxytoca - physiology</topic><topic>Klebsiella pneumoniae</topic><topic>Klebsiella pneumoniae - drug effects</topic><topic>Klebsiella pneumoniae - growth &amp; development</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Microbial Interactions</topic><topic>multidrug-resistant bacteria</topic><topic>probiotics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Osbelt, Lisa</creatorcontrib><creatorcontrib>Wende, Marie</creatorcontrib><creatorcontrib>Almási, Éva</creatorcontrib><creatorcontrib>Derksen, Elisabeth</creatorcontrib><creatorcontrib>Muthukumarasamy, Uthayakumar</creatorcontrib><creatorcontrib>Lesker, Till R.</creatorcontrib><creatorcontrib>Galvez, Eric J.C.</creatorcontrib><creatorcontrib>Pils, Marina C.</creatorcontrib><creatorcontrib>Schalk, Enrico</creatorcontrib><creatorcontrib>Chhatwal, Patrick</creatorcontrib><creatorcontrib>Färber, Jacqueline</creatorcontrib><creatorcontrib>Neumann-Schaal, Meina</creatorcontrib><creatorcontrib>Fischer, Thomas</creatorcontrib><creatorcontrib>Schlüter, Dirk</creatorcontrib><creatorcontrib>Strowig, Till</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Cell host &amp; microbe</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Osbelt, Lisa</au><au>Wende, Marie</au><au>Almási, Éva</au><au>Derksen, Elisabeth</au><au>Muthukumarasamy, Uthayakumar</au><au>Lesker, Till R.</au><au>Galvez, Eric J.C.</au><au>Pils, Marina C.</au><au>Schalk, Enrico</au><au>Chhatwal, Patrick</au><au>Färber, Jacqueline</au><au>Neumann-Schaal, Meina</au><au>Fischer, Thomas</au><au>Schlüter, Dirk</au><au>Strowig, Till</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Klebsiella oxytoca causes colonization resistance against multidrug-resistant K. pneumoniae in the gut via cooperative carbohydrate competition</atitle><jtitle>Cell host &amp; microbe</jtitle><addtitle>Cell Host Microbe</addtitle><date>2021-11-10</date><risdate>2021</risdate><volume>29</volume><issue>11</issue><spage>1663</spage><epage>1679.e7</epage><pages>1663-1679.e7</pages><issn>1931-3128</issn><eissn>1934-6069</eissn><abstract>Gut colonization with multidrug-resistant (MDR) bacteria enhances the risk of bloodstream infections in susceptible individuals. We demonstrate highly variable degrees of ex vivo colonization resistance against a carbapenem-resistant Klebsiella pneumoniae strain in human feces samples and subsequently isolate diverse K. oxytoca strains from protected donors. Several of these K. oxytoca strains reduce gut colonization of MDR K. pneumoniae strains in antibiotic-treated and gnotobiotic mouse models. Comparative analysis of K. oxytoca strains coupled with CRISPR-Cas9-mediated deletion of casA, a protein essential for utilization of selected beta-glucosides, identified competition for specific carbohydrates as key in promoting colonization resistance. In addition to direct competition between K. oxytoca and K. pneumoniae, cooperation with additional commensals is required to reestablish full colonization resistance and gut decolonization. Finally, humanized microbiota mice generated from K. pneumoniae-susceptible donors are protected by K. oxytoca administration, demonstrating the potential of commensal K. oxytoca strains as next-generation probiotics. [Display omitted] •Ex vivo colonization resistance against K. pneumoniae is variable between individuals•Diverse commensal Klebsiella oxytoca strains are isolated from protected individuals•K. oxytoca establishes colonization resistance against of K. pneumoniae in vivo•Cooperation with commensal bacteria restricts nutrient availability in the gut Gut colonization with multidrug-resistant enterobacteria increases risk of bloodstream infections. Osbelt et al. characterize the ability of human stools to inhibit growth of multidrug-resistant Klebsiella pneumoniae. Commensal Klebsiella oxytoca strains were identified in protected human donors, which in cooperation with other commensals outcompete K. pneumoniae through beta-glucoside utilization in mice.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>34610293</pmid><doi>10.1016/j.chom.2021.09.003</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1931-3128
ispartof Cell host & microbe, 2021-11, Vol.29 (11), p.1663-1679.e7
issn 1931-3128
1934-6069
language eng
recordid cdi_proquest_miscellaneous_2579628551
source MEDLINE; Cell Press Free Archives; Elsevier ScienceDirect Journals; EZB-FREE-00999 freely available EZB journals
subjects 16S rRNA gene sequencing
Adaptive Immunity
Adult
Animals
Bacterial Proteins - genetics
Bacterial Proteins - metabolism
beta-glucosides
Carbohydrate Metabolism
Child
colonization resistance
Drug Resistance, Multiple, Bacterial
enteric infections
Feces - microbiology
Gastrointestinal Microbiome
Gastrointestinal Tract - microbiology
Germ-Free Life
Glucosides - metabolism
humanized mouse models
Humans
intestinal microbiota
Klebsiella Infections - immunology
Klebsiella Infections - microbiology
Klebsiella oxytoca
Klebsiella oxytoca - genetics
Klebsiella oxytoca - isolation & purification
Klebsiella oxytoca - physiology
Klebsiella pneumoniae
Klebsiella pneumoniae - drug effects
Klebsiella pneumoniae - growth & development
Mice
Mice, Inbred C57BL
Microbial Interactions
multidrug-resistant bacteria
probiotics
title Klebsiella oxytoca causes colonization resistance against multidrug-resistant K. pneumoniae in the gut via cooperative carbohydrate competition
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T13%3A54%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Klebsiella%20oxytoca%20causes%20colonization%20resistance%20against%20multidrug-resistant%20K.%C2%A0pneumoniae%20in%20the%20gut%20via%20cooperative%20carbohydrate%20competition&rft.jtitle=Cell%20host%20&%20microbe&rft.au=Osbelt,%20Lisa&rft.date=2021-11-10&rft.volume=29&rft.issue=11&rft.spage=1663&rft.epage=1679.e7&rft.pages=1663-1679.e7&rft.issn=1931-3128&rft.eissn=1934-6069&rft_id=info:doi/10.1016/j.chom.2021.09.003&rft_dat=%3Cproquest_cross%3E2579628551%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2579628551&rft_id=info:pmid/34610293&rft_els_id=S1931312821004194&rfr_iscdi=true